A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Year: 2002
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: paclitaxel, cardiotoxicity, anthracycline cardiotoxicity, metastatic breast cancer, congestive heart failure, ejection fraction, endomyocardial biopsy, infusion duration, combination chemotherapy, treatment efficacy, dose-limiting toxicity, time to progression, survival, objective response rate
Open Access status: closed
OpenAlex ID: W2163106700
